Search

Your search keyword '"Lennon, Diana"' showing total 366 results
Start Over Author "Lennon, Diana"
366 results on '"Lennon, Diana"'

55. Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New Zealand

Author

Baker, Michael G, primary, Gurney, Jason, additional, Oliver, Jane, additional, Moreland, Nicole J, additional, Williamson, Deborah A, additional, Pierse, Nevil, additional, Wilson, Nigel, additional, Merriman, Tony R, additional, Percival, Teuila, additional, Murray, Colleen, additional, Jackson, Catherine, additional, Edwards, Richard, additional, Foster Page, Lyndie, additional, Chan Mow, Florina, additional, Chong, Angela, additional, Gribben, Barry, additional, and Lennon, Diana, additional

Published
2019
Full Text
View/download PDF

57. Community-acquired invasive Staphylococcus aureus: Uncovering disparities and the burden of disease in Auckland children.

Author

Vogel, Alison M, Borland, Annie, van der Werf, Bert, Morales, Adrienne, Freeman, Joshua, Taylor, Susan, Anderson, Phillipa, Horsfall, Maraekura, Drinkovic, Dragana, and Lennon, Diana R

Subjects
JUVENILE diseases, STAPHYLOCOCCUS aureus, RESPIRATORY infections in children, NOSOCOMIAL infections, RESPIRATORY infections, COMMUNITY-acquired infections, CROSS-sectional method, DISEASE incidence, RETROSPECTIVE studies, ECONOMIC aspects of diseases
Abstract

Aim: Staphylococcus aureus (SA) causes serious invasive disease in children. Large studies have measured the incidence of SA bacteraemia, but there is less information on the total burden of community-acquired invasive SA (iSA) in children.Methods: A retrospective, cross-sectional analysis of Auckland resident children aged 0-14 years who were hospitalised with iSA between 2011 and 2015 was performed. Laboratory databases and SA-related international classification of diseases 10 discharge codes were searched to identify community-onset cases with SA isolated from a normally sterile site. Clinical records and coroner's reports were reviewed to determine clinical syndromes and exclude nosocomial infections.Results: A total of 295 children with iSA were identified. The average annual incidence of iSA was 18.6 per 100 000 - for Pacific populations 44.3 per 100 000, Māori 24.3 per 100 000 and New Zealand European and other 8.8 per 100 000; 68% had bacteraemia. The incidence of iSA for Pacific infants was 10 times greater than non-Māori/non-Pacific (113.4/100 000 population vs. 11.8/100 000). Multivariate analysis found a higher risk of admission in Pacific children, males and those living in areas of high deprivation. Thirty-two patients (10.8%) were admitted to the intensive care unit; risk was higher in infants, Pacific children and those with respiratory infection (Relative Risk (RR) 12.2, 95% confidence interval (CI) 5.7-26.4) and multifocal (RR 6.9, 95% CI 3.4-13.8) and endovascular disease (RR 8.9, 95% CI 3.9-20.6). All deaths (n = 7) had respiratory infections, and four were patients <1 year of age.Conclusions: Studies investigating SA bacteraemia alone significantly underestimate the total burden of iSA disease. There are marked ethnic and socio-economic disparities in iSA disease among Auckland children. Pacific infants are at the highest risk. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

65. Post-streptococcal glomerulonephritis: Some reduction in a disease of disparities.

Author

Vogel, Alison M, Neutze, Jocelyn M, Lennon, Diana R, Diack, Max, van der Werf, Bert, Horsfall, Maraekura, Emery, Diane, and Wong, William

Subjects
GLOMERULONEPHRITIS, NOSOLOGY, MULTIVARIATE analysis, EDEMA, ELECTRONIC records, DISEASES
Abstract

Aim: A retrospective Auckland-wide (total population approximately 1.4 million) study of hospital admissions from 2007 to 2015 was conducted to assess trends in admissions for acute post-streptococcal glomerulonephritis (APSGN) in children aged 0-14 years.Methods: International Statistical Classification of Diseases (ICD10) discharge codes were used to identify potential cases of APSGN, and electronic clinical records and laboratory data were compared with established case definitions for definite or probable APSGN.Results: A total of 430 cases of APSGN were identified (definite n = 337, probable n = 93), with a mean annual incidence of 15.2/100 000 (95% confidence interval (CI) 14.9-15.6). Incidence (0-14 years) was 17 times higher in Pacific peoples (50.2/100 000, 95% CI 48.6-51.8) and almost 7 times higher in Māori (19.6/100 000, 95% CI 18.6-20.7) than European/other populations (2.9/100 000, 95% CI 2.7-3.1). Multivariate analysis found ethnicity, deprivation, male gender, age (peak 3-8 years) and season (summer/autumn) to be associated with admission risk. Admission rates showed a significant change of -9.0% (95% CI -10.4, 7.4%) per year, with 2011 being an exception. Low C3 complement, hypertension, elevated streptococcal titres, oedema and heavy proteinuria were present in 94, 65, 67, 52 and 49% of cases, respectively. Relying on ICD10 codes without further review of clinical notes would result in an overcount of cases by 25%.Conclusions: There is severe disparity in APSGN admission rates, with a disproportionate burden of disease for Pacific and Māori children and those living in deprived circumstances. Rates trended downward from 2007 to 2015. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

67. Contributors

Author

Aaskov, John, Adachi, Kristina, Aebi, Christoph, Alexander, Kenneth A., Al-Rawahi, Ghada N., Al-Zubeidi, Duha, Anjum, Seher, Ardura, Monica I., Arnon, Stephen S., Arrington, Amy, Arvin, Ann M., Atmar, Robert L., Baker, Amira, Baker, Carol J., Baltimore, Robert S., Barenkamp, Stephen J., Barnett, Elizabeth D., Barton, Theresa, Benard, Gil, Bender, Jeffrey M., Berry, Gregory J., Bhatt, Amit, Bluestone, Charles D., Blumer, Jeffrey L., Bocchini, Claire, Boyer, Kenneth M., Bradley, John S., Brasil, Patricia, Britt, William J., Bronstein, David E., Bruckner, David A., Bryant, Kristina A., Buckingham, Steven C., Byington, Carrie L., Cabada, Miguel M., Cadilla, Adriana, Campbell, Judith R., Caron, Justin E., Carrillo-Marquez, Maria, Casey, Janet R., Castagnini, Luis A., Chacko, Mariam R., Chandramohan, Lakshmi, Chapman, Louisa E., Charrel, Remi N., Chea-Woo, Elsa, Cheifetz, Ira M., Chen, Tempe K., Cherry, James D., Chinen, Javier, Ching, Natascha, Chinn, Ivan K., Christenson, John C., Coffin, Susan E., Correa, Armando G., Cox, Elaine G., Crews, Jonathan D., Cruz, Andrea T., Davidovics, Zev, Dehority, Walter N., de Lamballerie, Xavier, Dennehy, Penelope H., Doan, Minh L., Dobson, Simon R., Drutz, Jan E., Dubray, Kara A., Duppenthaler, Andrea, Dvorak, Christopher C., Edelstein, Paul H., Edwards, Kathryn M., Edwards, Morven S., El-Kamary, Samer S., Englund, Janet A., Ericson, Jessica, Fan, Leland L., Federman, Myke, Fernando, Pedro, Fischer, Philip R., Fisher, Brian T., Fisher, Randall G., Fishman, Douglas S., Flores, Anthony R., Foster, Catherine, Friedman, Ellen M., Gabaglia, Claudia Raja, Garcia, Lynne S., Gauthier, Gregory M., Gershon, Anne A., Gigliotti, Francis, Gilger, Mark A., Gillespie, Susan L., Glaser, Carol A., Goldman, David L., Goldman, Jennifer L., Goldstein, Nira A., Gonzalez, Blanca E., Green, Michael D., Groll, Andreas, Grose, Charles, Gubler, Duane J., Guevara, Javier Nieto, Hall, Caroline B., Hall, Roy A., Halstead, Scott B., Hamano, Shinjiro, Hammerschlag, Margaret R., Hannemann, Nicole L., Hanson, I. Celine, Harik, Nada, Harriman, Kathleen H., Harrison, Gail J., Healy, C. Mary, Heininger, Ulrich, Hemming-Harlo, Maria, Henderson, Sheryl L., Heresi, Gloria P., Hiatt, Peter W., Hill, Harry R., Hilmers, David C., Hoffman, Jill A., Hotez, Peter J., Howard, Leigh M., Hulten, Kristina G., Humphries, Romney M., Hunstad, David A., Hunt, W. Garrett, Huskins, W. Charles, Hyun, David Y., Jackson, Mary Anne, Jacobs, Michael R., Jacobs, Richard F., Jhaveri, Ravi, Odom, Audrey R., Johnston, Samantha H., Julapalli, Meena R., Kaplan, Sheldon L., Kearns, Gregory L., Khouri, Jessica M., Kim, Kwang Sik, Kim, Yae-Jean, King, Katherine Y., Kirchhoff, Louis V., Kleiman, Martin B., Klein, Bruce S., Kohlhoff, Stephan A., Kollmann, Tobias R., Korpe, Poonum S., Kosek, Margaret, Koster, Michael P., Krause, Peter J., Krilov, Leonard R., Krogstad, Paul, Krysan, Damian J., Kuan, Edward, Kuhls, Thomas, Labuda, Sarah M., Lantos, Paul M., La Pine, Timothy R., Heinimäki, Suvi, Larkin, Jerome M., Laurens, Matthew B., Leach, Charles T., Leber, Amy, Leggiadro, Robert J., Lehman, Deborah, Lennon, Diana R., Leung, Daniel H., Levy, Moise L., Linam, W. Matthew, Logan, Latania K., Lotze, Timothy E., Lucero, Yalda C., Lugo, Debra J., Luk, Berkley, Maloney, Susan A., Mann, Michelle C., Marquez, Lucila, Martin, Kimberly C., Mascola, Laurene, Mason, Edward O., Jr, Maspons, Aldo, Mazade, Marc A., McBride, Holly E., McCullers, Jonathan A., McIntosh, Kenneth, McJunkin, James E., McKee, Kelly T., Jr, McKinney, Ross, Jr, McNeil, J. Chase, Mejia, Rojelio, Mejias, Asuncion, Mendes Giannini, Maria José Soares, Michaels, Marian G., Michelow, Ian C., Miller, Marjorie J., Mills, James N., Mithal, Leena B., Moffett, Kathryn S., Montes, Martin, Muller, Martha, Mungwira, Randy George, Murphy, James R., Nadipuram, Santhosh M., Nataro, James P., Needham, Heather, Nielsen-Saines, Karin, Nieves, Delma J., Oberhelman, Richard, Ochoa, Theresa J., Olivero, Rosemary M., O'Ryan, Miguel, Overturf, Gary D., Palazzi, Debra L., Pannaraj, Pia S., Patel, Janak A., Paul, Mary E., Pelton, Stephen I., Pence, Morgan A., Perfect, John R., Peters, C.J., Petri, William A., Jr, Pham, Yen H., Pinheiro, Francisco P., Pinsky, Benjamin A., Pong, Alice, Porsch, Eric A., Purcell, Joan S., Quanquin, Natalie M., Quinn, Kevin K., Abdel-Rahman, Susan M., Ramilo, Octavio, Ramraj, Ramya, Revell, Paula A., Rimoin, Anne W., Romero, José R., Ross, Lawrence, Rowley, Anne H., Rupprecht, Charles E., Saez-Llorens, Xavier, Sammons, Julia Shaklee, Sánchez, Pablo, Sande, Linette, Santisteban-Ponce, Javier, Sass, Laura A., Scholand, Stephen J., Schulte, Danica J., Schuster, Jennifer E., Schutze, Gordon E., Seed, Patrick C., Serpa, Jose A., Shah, Samir S., Shapiro, Eugene D., Shapiro, Nina L., Shearer, William T., Shimizu-Cohen, Robyn, Shulman, Stanford T., Shehab, Kareem W., Shehab, Ziad M., Simos, Constantine, Smit, Michael A., Smith, P. Brian, Soni, Priya R., Sood, Sunil K., Staat, Mary Allen, Stark, Damien, Starke, Jeffrey R., Statler, Victoria A., Stechenberg, Barbara W., Steinbach, William J., St. Geme, Joseph W., III, Suen, Jeffrey, Sung, Lillian, Swanson, Douglas S., Tan, Tina Q., Taylor, Ruston S., Tolle, Michael A., Toltzis, Philip, Tomko, Stuart R., Tosi, Michael F., Tovar Padua, Leidy J., Travassos da Rosa, Amelia P.A., Tsai, Theodore F., Vahabzadeh-Hagh, Andrew M., Velarde, Jorge J., Vallejo, Jesus G., Vanchiere, John A., Venick, Robert S., Verma, Sanjay, Versalovic, James, Vesikari, Timo, Wald, Ellen R., Walsh, Thomas J., Ward, Mark A., Wattier, Rachel L., Way, Sing Sing, Weatherhead, Jill, Weinberg, Michelle, Weinberg, Nicholas, Wellington, Melanie, Welliver, Robert C., Sr, Wheeler, J. Gary, White, A. Clinton, Jr, Whitworth, Suzanne, Wiedermann, Bernhard L., Williams, John V., Williams-Bouyer, Natalie M., Woods, Charles R., Jr, Wright, Terry W., Yeganeh, Nave, Young, Edward J., Zakhour, Ramia, and Zaoutis, Theoklis

Published
2019
Full Text
View/download PDF

79. Working towards a Group A Streptococcal vaccine: Report of a collaborative Trans-Tasman workshop.

Author

Moreland, Nicole J, Waddington, Claire S, Williamson, Deborah A, Sriskandan, Shiranee, Smeesters, Pierre, Proft, Thomas, Steer, Andrew C, Walker, Mark J, Baker, Edward N, Baker, Michael G, Lennon, Diana, Dunbar, Rod, Carapetis, Jonathan Rhys, Fraser, John D, Moreland, Nicole J, Waddington, Claire S, Williamson, Deborah A, Sriskandan, Shiranee, Smeesters, Pierre, Proft, Thomas, Steer, Andrew C, Walker, Mark J, Baker, Edward N, Baker, Michael G, Lennon, Diana, Dunbar, Rod, Carapetis, Jonathan Rhys, and Fraser, John D

Abstract

Group A Streptococcus (GAS) infections represent a major public health burden in both developing and developed countries. In Australia and New Zealand GAS associated diseases are serious problems in Indigenous populations and a major cause of health inequality. Political recognition of these inequalities is providing impetus for strategies that reduce GAS disease and the development of a GAS vaccine now has governmental support in both Australia and New Zealand. Accordingly, an expert workshop was convened in March 2013 to consider available data on GAS vaccines. M-protein based vaccines constructed from the hyper-variable N-terminal region (30-valent vaccine) or the conserved C-repeat domain (J8 vaccine) were reviewed together with vaccine candidates identified using multi high-throughput approaches. Performing a comprehensive assessment of regional GAS strain epidemiology, defining the immune correlates of protection, and the establishment of clinical trial sites were identified as critical activities for a Trans-Tasman vaccine development programme., Journal Article, SCOPUS: cp.j, info:eu-repo/semantics/published

Published
2014

83. Working towards a Group A Streptococcal vaccine: Report of a collaborative Trans-Tasman workshop

Author

Moreland, Nicole J., primary, Waddington, Claire S., additional, Williamson, Deborah A., additional, Sriskandan, Shiranee, additional, Smeesters, Pierre R., additional, Proft, Thomas, additional, Steer, Andrew C., additional, Walker, Mark J., additional, Baker, Edward N., additional, Baker, Michael G., additional, Lennon, Diana, additional, Dunbar, Rod, additional, Carapetis, Jonathan, additional, and Fraser, John D., additional

Published
2014
Full Text
View/download PDF

93. Delayed immunisation and risk of pertussis in infants: unmatched case-control study. (Papers)

Author

Grant, Cameron C., Roberts, Mavis, Scragg, Robert, Stewart, Joanna, Lennon, Diana, Kivell, Denise, Ford, Rodney, and Menzies, Rosalie

Subjects
Pertussis vaccines -- Dosage and administration, Infants -- Diseases, Whooping-cough -- Risk factors, Health, Diseases, Risk factors, Dosage and administration
Abstract

Pertussis remains a severe disease in infants. As about two thirds of infants with pertussis are admitted to hospital, factors that seem to be associated with an increased risk of [...]

Published
2003

94. From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease

Author

O'Hallahan, Jane, Lennon, Diana, Oster, Philipp, Lane, Robbie, Reid, Stewart, Mulholland, E. Kim, Stewart, Joanna, Penney, Liane, Percival, Teuila, Martin, Diana, O'Hallahan, Jane, Lennon, Diana, Oster, Philipp, Lane, Robbie, Reid, Stewart, Mulholland, E. Kim, Stewart, Joanna, Penney, Liane, Percival, Teuila, and Martin, Diana

Abstract

New Zealand has been affected by an epidemic of group B meningococcal disease dominated by a strain defined as, B:4:P1.7b,4. Over 5550 cases and 222 deaths have been reported since 1991 in a population of 4 million people. Through the collaborative efforts of a government agency, vaccine company, university and laboratory institute, clinical trials of the Chiron produced outer membrane vesicle (OMV) strain-specific MeNZB™ vaccine were run in rapid succession. The delivery of MeNZB™ will be New Zealand's largest immunisation programme with three doses given at 6-week intervals to over 1 million people aged 6 weeks–19 year olds inclusive. Planning, co-ordinating and delivering the immunisation programme is a challenging project for the New Zealand Health Sector.

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results